CRP and renal cell carcinoma: Furthermore, clinical indices including blood routine, C-reactive protein, liver and kidney function, and electrolyte analysis were performed to evaluate the clinical status difference between the RCC group and the Control group (Figure 3A and Supplementary Figure 7).